Lista de obras - Valentina Ambrosini - Dominio Público Uruguay

(11)C-Choline PET/CT in patients with hormone-resistant prostate cancer showing biochemical relapse after radical prostatectomy.

artículo científico publicado en 2012

(18)F-FDG PET in Pediatric Lymphomas: A Comparison with Conventional Imaging

artículo científico publicado en 2008

(18)F-FDG PET/CT for the assessment of disease extension and activity in patients with sarcoidosis: results of a preliminary prospective study

artículo científico publicado en 2013

(68)Ga-DOTA-NOC PET/CT in comparison with CT for the detection of bone metastasis in patients with neuroendocrine tumours

artículo científico publicado en 2010

(68)Ga-somatostatin analogues PET and (18)F-DOPA PET in medullary thyroid carcinoma

artículo científico publicado en 2010

111In-pentetreotide scintigraphy: procedure guidelines for tumour imaging

artículo científico publicado en 2010

11C-choline vs. 18F-FDG PET/CT in assessing bone involvement in patients with multiple myeloma

artículo científico publicado en 2007

18F-FACBC compared with 11C-choline PET/CT in patients with biochemical relapse after radical prostatectomy: a prospective study in 28 patients.

artículo científico publicado en 2013

18F-FDG PET in mucosa-associated lymphoid tissue (MALT) lymphoma

artículo científico publicado en 2006

18F-FDG PET/CT detects systemic involvement in sarcoidosis

artículo científico publicado en 2011

18F-FDG PET/CT impact on testicular tumours clinical management.

artículo científico publicado en 2013

68Ga DOTANOC PET/CT detects primary malignant insulinoma.

artículo científico publicado en 2015

68Ga-DOTA-NOC: a new PET tracer for evaluating patients with bronchial carcinoid

artículo científico publicado en 2009

68Ga-DOTA-peptides in the diagnosis of NET.

artículo científico

68Ga-DOTA-peptides versus 18F-DOPA PET for the assessment of NET patients

artículo científico publicado en 2008

68Ga-DOTANOC PET/CT allows somatostatin receptor imaging in idiopathic pulmonary fibrosis: preliminary results

artículo científico publicado en 2010

68Ga-citrate PET/CT for evaluating patients with infections of the bone: preliminary results.

artículo científico publicado en 2010

A new dimension of FDG-PET interpretation: assessment of tumor biology.

artículo científico publicado en 2011

Antitumor activity of sustained N-myc reduction in rhabdomyosarcomas and transcriptional block by antigene therapy

artículo científico publicado en 2011

Assessment of a chemically induced model of lung squamous cell carcinoma in mice by 18F-FDG small-animal PET.

artículo científico

Cardiac FDG PET/CT is useful to assess the culprit lesion in nonST-segment elevation myocardial infarction (NSTEMI).

artículo científico publicado en 2013

Comparison between 68Ga-DOTA-NOC and 18F-DOPA PET for the detection of gastro-entero-pancreatic and lung neuro-endocrine tumours

artículo científico publicado en 2008

Comparison of 18F-DOPA, 18F-FDG and 68Ga-somatostatin analogue PET/CT in patients with recurrent medullary thyroid carcinoma

artículo científico publicado en 2012

Comparison of 18F-FACBC and 11C-choline PET/CT in patients with radically treated prostate cancer and biochemical relapse: preliminary results

artículo científico publicado en 2013

Detection of unknown primary neuroendocrine tumours (CUP-NET) using (68)Ga-DOTA-NOC receptor PET/CT.

artículo científico publicado en 2010

Diagnostic accuracy of FDG PET/CT in mediastinal lymph nodes from lung cancer.

artículo científico publicado en 2014

Discordant response to chemotherapy: An unusual patternof fluoro-deoxy-d-glucose uptake in heavily pre-treated lymphoma patients

artículo científico publicado en 2006

Dual PET/CT with (18)F-DOPA and (18)F-FDG in metastatic medullary thyroid carcinoma and rapidly increasing calcitonin levels: Comparison with conventional imaging

artículo científico publicado en 2010

Early relapse in a patient with Hodgkin's disease and negative interim FDG-PET.

artículo científico publicado en 2008

Epithelial and mesenchymal tumor compartments exhibit in vivo complementary patterns of vascular perfusion and glucose metabolism.

artículo científico publicado en 2007

Evaluation of unusual neuroendocrine tumours by means of 68Ga-DOTA-NOC PET.

artículo científico publicado en 2008

Evolving paradigms for successful molecular imaging of medullary thyroid carcinoma

artículo científico publicado en 2012

FDG PET/CT in autoimmune pancreatitis

article

FDG PET/CT is useful for the interim evaluation of response to therapy in patients affected by haematogenous spondylodiscitis

artículo científico publicado en 2012

FDG small animal PET permits early detection of malignant cells in a xenograft murine model.

artículo científico publicado en 2006

Focal lung uptake of 18F-fluorodeoxyglucose (18F-FDG) without computed tomography findings.

artículo científico publicado en 2005

Gene transcript analysis blood values correlate with ⁶⁸Ga-DOTA-somatostatin analog (SSA) PET/CT imaging in neuroendocrine tumors and can define disease status.

artículo científico publicado en 2015

Incidence of increased 68Ga-DOTANOC uptake in the pancreatic head in a large series of extrapancreatic NET patients studied with sequential PET/CT

scientific article published on 13 May 2011

Is there a role for ¹¹C-choline PET/CT in the early detection of metastatic disease in surgically treated prostate cancer patients with a mild PSA increase <1.5 ng/ml?

artículo científico publicado en 2010

Is there an ideal diagnostic algorithm in solitary pulmonary nodules?

artículo científico publicado en 2006

Is ⁶⁸Ga-DOTA-NOC PET/CT indicated in patients with clinical, biochemical or radiological suspicion of neuroendocrine tumour?

artículo científico publicado en 2012

Late FDG PET normalization after radioimmunotherapy in a patient with non-Hodgkin lymphoma.

artículo científico publicado en 2009

Molecular imaging of neuroblastoma progression in TH-MYCN transgenic mice.

artículo científico publicado en 2013

Molecular imaging of pulmonary nodules

artículo científico publicado en 2014

PET/CT imaging in different types of lung cancer: an overview

artículo científico publicado en 2011

PET/CT in Neuroendocrine Tumors

artículo científico publicado en 2008

PET/CT in Neuroendocrine Tumors: Evaluation of Receptor Status and Metabolism

artículo científico publicado en 2008

PET/CT with 68Gallium-DOTA-peptides in NET: an overview

artículo científico publicado en 2010

Performance evaluation of a small animal PET scanner. Spatial resolution characterization using 18F and 11C

article published in 2007

Performance of FDG PET/ceCT in the evaluation of patients with lung cancer

artículo científico publicado en 2014

Positron-emission tomography in gynaecologic malignancies

artículo científico publicado en 2009

Procedure guidelines for PET/CT tumour imaging with 68Ga-DOTA-conjugated peptides: 68Ga-DOTA-TOC, 68Ga-DOTA-NOC, 68Ga-DOTA-TATE.

artículo científico publicado en 2010

Radiopeptide imaging and therapy in Europe

artículo científico publicado en 2011

Retro-orbital injection is an effective route for radiopharmaceutical administration in mice during small-animal PET studies.

artículo científico publicado en 2007

Role of 18F-FDG-PET and PET/CT imaging in thyroid cancer.

artículo científico publicado en 2006

Role of 18F-dopa PET/CT imaging in the management of patients with 111In-pentetreotide negative GEP tumours.

artículo científico publicado en 2007

Role of [18F]fluorodeoxyglucose positron emission tomography scan in the follow-up of lymphoma

artículo científico publicado en 2009

Small animal PET for the evaluation of an animal model of genital infection

artículo científico publicado en 2009

Small animal PET in oncology: the road from bench to bedside

scientific article published on April 2009

Standardized uptake values of (68)Ga-DOTANOC PET: a promising prognostic tool in neuroendocrine tumors

artículo científico publicado en 2010

The additional diagnostic value of contemporary evaluation of FDG PET/CT scan and contrast enhanced CT imaging both acquired by a last generation PET/CT system in oncologic patients.

artículo científico publicado en 2012

The detection of disease relapse after radical treatment for prostate cancer: is anti-3-18F-FACBC PET/CT a promising option?

artículo científico publicado en 2013

The use of gallium-68 labeled somatostatin receptors in PET/CT imaging

artículo científico publicado en 2014

The value of 18F-FDG PET/CT after autologous stem cell transplantation (ASCT) in patients affected by multiple myeloma (MM): experience with 77 patients.

artículo científico publicado en 2013

Value of FDG PET/CT in patients with treated ovarian cancer and raised CA125 serum levels.

artículo científico publicado en 2012

¹⁸F-FDG PET/CT diagnosis of unexpected extracardiac septic embolisms in patients with suspected cardiac endocarditis.

artículo científico publicado en 2013

⁶⁸Ga-labelled peptides for diagnosis of gastroenteropancreatic NET.

artículo científico

Lista de obras de Valentina Ambrosini

(11)C-Choline PET/CT in patients with hormone-resistant prostate cancer showing biochemical relapse after radical prostatectomy.

(18)F-FDG PET in Pediatric Lymphomas: A Comparison with Conventional Imaging

(18)F-FDG PET/CT for the assessment of disease extension and activity in patients with sarcoidosis: results of a preliminary prospective study

(68)Ga-DOTA-NOC PET/CT in comparison with CT for the detection of bone metastasis in patients with neuroendocrine tumours

(68)Ga-somatostatin analogues PET and (18)F-DOPA PET in medullary thyroid carcinoma

111In-pentetreotide scintigraphy: procedure guidelines for tumour imaging

11C-choline vs. 18F-FDG PET/CT in assessing bone involvement in patients with multiple myeloma

18F-FACBC compared with 11C-choline PET/CT in patients with biochemical relapse after radical prostatectomy: a prospective study in 28 patients.

18F-FDG PET in mucosa-associated lymphoid tissue (MALT) lymphoma

18F-FDG PET/CT detects systemic involvement in sarcoidosis

18F-FDG PET/CT impact on testicular tumours clinical management.

68Ga DOTANOC PET/CT detects primary malignant insulinoma.

68Ga-DOTA-NOC: a new PET tracer for evaluating patients with bronchial carcinoid

68Ga-DOTA-peptides in the diagnosis of NET.

68Ga-DOTA-peptides versus 18F-DOPA PET for the assessment of NET patients

68Ga-DOTANOC PET/CT allows somatostatin receptor imaging in idiopathic pulmonary fibrosis: preliminary results

68Ga-citrate PET/CT for evaluating patients with infections of the bone: preliminary results.

A new dimension of FDG-PET interpretation: assessment of tumor biology.

Antitumor activity of sustained N-myc reduction in rhabdomyosarcomas and transcriptional block by antigene therapy

Assessment of a chemically induced model of lung squamous cell carcinoma in mice by 18F-FDG small-animal PET.

Cardiac FDG PET/CT is useful to assess the culprit lesion in nonST-segment elevation myocardial infarction (NSTEMI).

Comparison between 68Ga-DOTA-NOC and 18F-DOPA PET for the detection of gastro-entero-pancreatic and lung neuro-endocrine tumours

Comparison of 18F-DOPA, 18F-FDG and 68Ga-somatostatin analogue PET/CT in patients with recurrent medullary thyroid carcinoma

Comparison of 18F-FACBC and 11C-choline PET/CT in patients with radically treated prostate cancer and biochemical relapse: preliminary results

Detection of unknown primary neuroendocrine tumours (CUP-NET) using (68)Ga-DOTA-NOC receptor PET/CT.

Diagnostic accuracy of FDG PET/CT in mediastinal lymph nodes from lung cancer.

Discordant response to chemotherapy: An unusual patternof fluoro-deoxy-d-glucose uptake in heavily pre-treated lymphoma patients

Dual PET/CT with (18)F-DOPA and (18)F-FDG in metastatic medullary thyroid carcinoma and rapidly increasing calcitonin levels: Comparison with conventional imaging

Early relapse in a patient with Hodgkin's disease and negative interim FDG-PET.

Epithelial and mesenchymal tumor compartments exhibit in vivo complementary patterns of vascular perfusion and glucose metabolism.

Evaluation of unusual neuroendocrine tumours by means of 68Ga-DOTA-NOC PET.

Evolving paradigms for successful molecular imaging of medullary thyroid carcinoma

FDG PET/CT in autoimmune pancreatitis

FDG PET/CT is useful for the interim evaluation of response to therapy in patients affected by haematogenous spondylodiscitis

FDG small animal PET permits early detection of malignant cells in a xenograft murine model.

Focal lung uptake of 18F-fluorodeoxyglucose (18F-FDG) without computed tomography findings.

Gene transcript analysis blood values correlate with ⁶⁸Ga-DOTA-somatostatin analog (SSA) PET/CT imaging in neuroendocrine tumors and can define disease status.

Incidence of increased 68Ga-DOTANOC uptake in the pancreatic head in a large series of extrapancreatic NET patients studied with sequential PET/CT

Is there a role for ¹¹C-choline PET/CT in the early detection of metastatic disease in surgically treated prostate cancer patients with a mild PSA increase <1.5 ng/ml?

Is there an ideal diagnostic algorithm in solitary pulmonary nodules?

Is ⁶⁸Ga-DOTA-NOC PET/CT indicated in patients with clinical, biochemical or radiological suspicion of neuroendocrine tumour?

Late FDG PET normalization after radioimmunotherapy in a patient with non-Hodgkin lymphoma.

Molecular imaging of neuroblastoma progression in TH-MYCN transgenic mice.

Molecular imaging of pulmonary nodules

PET/CT imaging in different types of lung cancer: an overview

PET/CT in Neuroendocrine Tumors

PET/CT in Neuroendocrine Tumors: Evaluation of Receptor Status and Metabolism

PET/CT with 68Gallium-DOTA-peptides in NET: an overview

Performance evaluation of a small animal PET scanner. Spatial resolution characterization using 18F and 11C

Performance of FDG PET/ceCT in the evaluation of patients with lung cancer

Positron-emission tomography in gynaecologic malignancies

Procedure guidelines for PET/CT tumour imaging with 68Ga-DOTA-conjugated peptides: 68Ga-DOTA-TOC, 68Ga-DOTA-NOC, 68Ga-DOTA-TATE.

Radiopeptide imaging and therapy in Europe

Retro-orbital injection is an effective route for radiopharmaceutical administration in mice during small-animal PET studies.

Role of 18F-FDG-PET and PET/CT imaging in thyroid cancer.

Role of 18F-dopa PET/CT imaging in the management of patients with 111In-pentetreotide negative GEP tumours.

Role of [18F]fluorodeoxyglucose positron emission tomography scan in the follow-up of lymphoma

Small animal PET for the evaluation of an animal model of genital infection

Small animal PET in oncology: the road from bench to bedside

Standardized uptake values of (68)Ga-DOTANOC PET: a promising prognostic tool in neuroendocrine tumors

The additional diagnostic value of contemporary evaluation of FDG PET/CT scan and contrast enhanced CT imaging both acquired by a last generation PET/CT system in oncologic patients.

The detection of disease relapse after radical treatment for prostate cancer: is anti-3-18F-FACBC PET/CT a promising option?

The use of gallium-68 labeled somatostatin receptors in PET/CT imaging

The value of 18F-FDG PET/CT after autologous stem cell transplantation (ASCT) in patients affected by multiple myeloma (MM): experience with 77 patients.

Value of FDG PET/CT in patients with treated ovarian cancer and raised CA125 serum levels.

¹⁸F-FDG PET/CT diagnosis of unexpected extracardiac septic embolisms in patients with suspected cardiac endocarditis.

⁶⁸Ga-labelled peptides for diagnosis of gastroenteropancreatic NET.